NCT01467518 Methadone-Dolutegravir (DTG - GSK1349572) Drug Interaction Study. Status COMPLETED Phase PHASE1
NCT01467310 Defining the Triple Negative Breast Cancer Kinome Response to GSK1120212 Status COMPLETED Phase EARLY_PHASE1
NCT01466972 Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib Status COMPLETED Phase PHASE2
NCT01466361 Evaluation of the Nicotine Lozenge in Relief of Provoked Acute Craving Status COMPLETED Phase PHASE2
NCT01466335 An Adaptive Phase I Study to Evaluate the Safety, Efficacy and Dose Responses of Ronacaleret in Healthy Human Volunteers Status COMPLETED Phase PHASE1
NCT01466322 A Study to Assess the Relative Bioavailability of Different Formulations of GSK2018682, a Sphingosine-1-phosphate Receptor Subtype 1 Agonist, in Healthy Volunteers. Status COMPLETED Phase PHASE1
NCT01465659 Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery Status COMPLETED Phase PHASE1/PHASE2
NCT01465334 Ofatumumab With High Dose Methylprednisone Followed by Ofatumumab and Alemtuzumab in 17p CLL Status TERMINATED Phase PHASE2
NCT01462669 Crossover Study to Evaluate the Pharmacokinetics of Ezogabine/Retigabine in Taiwanese Subjects Status COMPLETED Phase PHASE1
NCT01462617 Study to Investigate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Single & Repeat Doses of GSK2269557 Status COMPLETED Phase PHASE1
NCT01462604 Pilot Study of Patient's Adherence to TYKERB™/TYVERB™ + Capecitabine in Metastatic Breast Cancer Status COMPLETED Phase N/A
NCT01462565 Study of a New Thermo Stable Formulation of Epoprostenol Sodium to Treat Pulmonary Arterial Hypertension (PAH) Status COMPLETED Phase PHASE4
NCT01462357 Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Human Papillomavirus (HPV) Vaccine (GSK-580299) and Merck's Gardasil Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old Females Status COMPLETED Phase PHASE3
NCT01462344 6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old Status COMPLETED Phase PHASE4